Strategic Investment for Future Growth Srinivas Sadu, Executive Chairman of Gland Pharma, commented on the expansion: "Our investments in global CDMO expansion, capacity enhancement in high-end modalities and complex injectables pipeline continue to strengthen our foundation and support sustainable growth and long-term value for all stakeholders." This capacity expansion aligns with Gland Pharma's strategy to diversify its product portfolio and tap into emerging pharmaceutical trends
This silky, fast-absorbing formula was designed to hydrate without leaving any greasy, pore-clogging residue
The Menopause Society's position on compounded bioidentical hormone therapy identifies specific concerns: minimal government regulation and monitoring, risk of overdosing or underdosing, potential for impurities or lack of sterility, and a lack of the kind of controlled safety and efficacy data that backs FDA-approved products
KFF Health Tracking Poll: Prescription Drug Costs, Views on Trump Administration Actions, and GLP-1 Use Findings Key Takeaways With the Trump administration recently announcing several high-profile prescription drug pricing deals, the latest polling from KFF suggests that few think it is likely the Trump administrations actions will lower their prescription drug costs, but his base remains more positive
Metabolism Booster: Accelerates metabolic rate and converts accumulated fat into vital body energy
Study populations include healthy adults under stress, older adults with memory impairment, and clinical cohorts with insomnia, schizophrenia, hypothyroidism, or infertility [26,35]